EMBC
Embecta Corp. Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Embecta (EMBC) Stock: Buy, Sell, or Hold?
$6.43
+0.00 (+0.00%)
â˛
5d:
-1.38%
30d:
+3.71%
90d:
+25.83%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (44%)
Quality Score
45/100
Position
FAIR
30-Day Fair Range
$6.00 â $6.60
Position: FAIR
Forward P/E & Valuation
3.7x
STRETCHED
vs 3.0x historical avg
Wall Street Target
$4.00
-37.8% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$5.78 / $6.79
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: EMBC is fairly priced but lacks strong directional signals. At 6.5% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Get Alerted When EMBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.28
Based on 0.0% avg growth
INTRINSIC VALUE TODAY
$3.28
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EMBC is currently trading at $6.43, which is considered fair relative to its 30-day fair value range of $6.00 to $6.60. From a valuation perspective, the stock is trading at a premium (Forward PE: 3.6) compared to its historical average (3.0). At these levels, the market is pricing in 6.5% annual earnings growth.
Technical Outlook: Technically, EMBC is in a strong uptrend. Immediate support is located at $5.78, while resistance sits at $6.79.
Market Sentiment: EMBC scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $4.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EMBC is in a strong uptrend. Immediate support is located at $5.78, while resistance sits at $6.79.
Market Sentiment: EMBC scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $4.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$6.00 -
$6.60
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
43.8%
Trading Range & Key Levels
30-Day Trading Range
$6.00 -
$6.60
Current vs Trading Range
FAIR
Support Level
$5.78
Resistance Level
$6.79
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (31/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 37.8% above Wall St target ($4.00)
- BULLISH: Expecting earnings turnaround to 6.5% growth with -8.1% revenue growth
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
3.65
Wall Street Target
$4.00
(-37.8%)
Revenue Growth (YoY)
-8.1%
Earnings Growth (YoY)
-53.7%
Profit Margin
8.6%
Valuation Premium vs History
+6.5% premium
PE vs Historical
3.7 vs 3.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.5%
(market-implied from PE analysis)
1-Year Target
$6.85
(+7%)
2-Year Target
$7.29
(+13%)
3-Year Target
$7.77
(+21%)
3-Yr Target (if PE normalizes)
(PE: 4â3)
PE COMPRESSION
$6.39
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: -4.0%)
$31.02
(+382%)
Base:
(SPY PE: 3.6, Growth: -4.0%)
$5.70
(-11%)
Bear:
(PE: 3.0, Growth: -4.0%)
$4.69
(-27%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (4x PE), but valuation improves significantly next year (4x PE) as earnings recover.
Trailing PE: 4.36 | Current EPS (TTM): $1.47
Bull Case
$8.45
(+32%)
Analyst growth 19.9%, PE expands to 4.8
Base Case
$7.69
(+20%)
Market implied 19.9%, PE stable at 4.4
Bear Case
$4.36
(-32%)
Severe decline -20.0%, PE contracts to 3.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share EMBC Analysis
Share this live EMBC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (EMBC)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 14, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits user shared their profit-taking experience with $EMBC, expressing confidence in the company.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:58 AM ET
Data refreshes hourly during market hours. Next update: 10:58 AM
Data refreshes hourly during market hours. Next update: 10:58 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EMBC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$486 | 39 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
21 analysts |
$203 | 65 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$82 | 27 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
16 analysts |
$471 | 52 HOLD |
|
RMD
ResMed Inc |
HOLD
20 analysts |
$264 | 52 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive EMBC Research Pages
